438 related articles for article (PubMed ID: 26551459)
1. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis.
Liu A; Zhang Z; Xu W; Qin S; Hua M; Zeng S; Xu C
Mol Med Rep; 2018 Dec; 18(6):5437-5444. PubMed ID: 30365104
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
Hu H; Chen Y; Cheng S; Li G; Zhang Z
Wien Klin Wochenschr; 2017 Jun; 129(11-12):391-397. PubMed ID: 27830363
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
5. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
6. Identification of differentially expressed long noncoding RNAs in bladder cancer.
Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW
Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
8. Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer.
Duan W; Du L; Jiang X; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2016 Nov; 7(48):78850-78858. PubMed ID: 27793008
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of LncRNA MIR31HG in human bladder cancer.
He A; Chen Z; Mei H; Liu Y
Cancer Biomark; 2016 Jul; 17(2):231-6. PubMed ID: 27434291
[TBL] [Abstract][Full Text] [Related]
10. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
12. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value.
Zhang W; Wang L; Zheng F; Zou R; Xie C; Guo Q; Hu Q; Chen J; Yang X; Yao H; Song E; Xiang Y
Biomed Res Int; 2015; 2015():618924. PubMed ID: 26448942
[TBL] [Abstract][Full Text] [Related]
14. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
Deng J; Liang Y; Liu C; He S; Wang S
Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
Shang C; Guo Y; Zhang H; Xue YX
Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
18. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel six-long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma.
Gao X; Zhang S; Chen Y; Wen X; Chen M; Wang S; Zhang Y
J Cell Biochem; 2019 Dec; 120(12):19796-19809. PubMed ID: 31338862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]